AzTrials
AzTrials

AnesthesiaPROVENTIPEDNCT03901599

Protective Ventilation Based on Alveolar Ventilation in Children

An observational study of Anesthesia and Peroperative Complication, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Protective ventilation decreased morbidity and mortality in adults' patients and is now a standard of care in intensive care unit and in anesthesiology. In children, there is no evidence in the literature to recommend protective ventilation during anaesthesia. Read more about this study

Who is it for?
Ages 2 months to 12 years
Conditions the study is for
Anesthesia, Peroperative Complication
What is being tested?
Alveolar ventilation monitoring estimated by the capnographic ventilation
How many people
60 participants
Where
1 siteFrance
Study dates
16 May 2019to 27 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 months to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children under general anaesthesia

Who may be able to join

  • Children aged < 12 and
  • Weight between 5 and 40kg
  • General anesthesia
  • Non-opposition of parents or legal guardians

Who cannot join

  • History of bronchodysplasia or laryngo tracheo malacia, cyanotic heart disease or neuromuscular disease
  • Airleaks > 10%
  • Bronchospasm during anesthesia

Trial locations and contacts

1 site in 1 country.

France1 site
  • Pediatric anesthesia division, Hôpital Femme Mère Enfant, Hospices Civils de Lyon

    Bron, 69500

Other trials in France

About this study

Official title: Feasibility of Protective Ventilation Based on the Alveolar Ventilation in Paediatric Anaesthesiology and Intensive Care.

Protective ventilation decreased morbidity and mortality in adults' patients and is now a standard of care in intensive care unit and in anesthesiology. In children, there is no evidence in the literature to recommend protective ventilation during anaesthesia. Moreover the ratio of instrumental dead space to tidal volume is higher in children than in adults. Therefore, it is difficult to propose an "optimal" tidal volume for all children. The objective of this study is to evaluate the use of alveolar ventilation (estimated by the volumetric capnography) in children under anesthesia. The hypothesis is that in children, alveolar ventilation reported to ideal body weight is a constant to maintain normocarbia, unlike the tidal volume.

Being tested
Alveolar ventilation monitoring estimated by the capnographic ventilation
Medical subject headings
Intraoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alveolar ventilation monitoring estimated by the capnographic ventilationOther

    Children are monitored using end-tidal CO2, Transcutaneous CO2 and volumetric capnographic. Respiratory rate is set using textbooks and guidelines (pediatric advanced life support). The physician in charge adapts the volume to target a CO2 between 38 and 42 mmHg. Data are recorded after a stabilization period of at least 5 minutes.

Study groups in NCT03901599
Study groupRoleWhat they receive
Children between 5-10KgChildren with a body weight between 5-10Kg
Receives: Other: Alveolar ventilation monitoring estimated by the capnographic ventilation
Children between 10-20KgChildren with a body weight between 10-20Kg
Receives: Other: Alveolar ventilation monitoring estimated by the capnographic ventilation
Children between 20-40KgChildren with a body weight between 20-40Kg
Receives: Other: Alveolar ventilation monitoring estimated by the capnographic ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determination of target alveolar minute volume to maintain normocapnia in children without mechanical ventilation.

    The minute alveolar ventilation estimated by the volumetric capnography reported to the ideal body weight based on 100 breaths (expressed in ml/Kg/min).

    Measured: 5 minutes after hemodynamic and ventilatory stabilization period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2019
  2. Study start16 May 2019
  3. Primary completion27 Oct 2019
  4. Study completion27 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03901599
Sponsor's protocol ID
69HCL19_0114
Acronym
PROVENTIPED
Status last verified
Aug 2025
First submitted
2 Apr 2019
Last updated
4 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gardon A, De Queiroz Siqueira M, Cerceuil E, Bouhamri N, Chassard D, Baudin F. Alveolar target ventilation and dead space in children under anaesthesia: The proventiped cohort study. Eur J Anaesthesiol. 2023 Jul 1;40(7):495-500. doi: 10.1097/EJA.0000000000001832. Epub 2023 Apr 12.

    PubMed 37052073

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia and Peroperative Complication, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determination of target alveolar minute volume to maintain normocapnia in children without mechanical ventilation. (time frame: 5 minutes after hemodynamic and ventilatory stabilization period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03901599, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in